EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Evolving landscape of detection and targeting miRNA/epigenetics for therapeutic strategies in ovarian cancer

Arpan Dey Bhowmik, Pallab Shaw, Mohan Shankar Gopinatha Pillai, Geeta Rao, Shailendra Kumar Dhar Dwivedi

Cancer Letters · 2025

DOI: 10.1016/j.canlet.2024.217357 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Letters, 2025. Verfasst von Arpan Dey Bhowmik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA; Department of Obstetrics an…. Hauptthemen laut MEDLINE: MicroRNAs, Ovarian Neoplasms, Epigenesis, Genetic, Biomarkers, Tumor. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 375 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, DOD, NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer (OC) accounts for the highest mortality rates among all gynecologic malignancies. The high mortality of OC is often associated with delayed detection, prolonged latency, enhanced metastatic potential, acquired drug resistance, and frequent recurrence. This review comprehensively explores key aspects of OC, including cancer diagnosis, mechanisms of disease resistance, and the pivotal role of epigenetic regulation, particularly by microRNAs (miRs) in cancer progression. We highlight the intricate regulatory mechanisms governing miR expression within the context of OC and the current status of epigenetic advancement in the therapeutic development and clinical trial progression. Through network analysis we elucidate the regulatory interactions between dysregulated miRs in OC and their targets which are involved in different signaling pathways. By exploring these interconnected facets and critical analysis, we endeavor to provide a nuanced understanding of the molecular dynamics underlying OC, its detection and shedding light on potential avenues for miRs and epigenetics-based therapeutic intervention and management strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsOvarian NeoplasmsEpigenesis, GeneticBiomarkers, TumorHumansFemaleGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmAnimalsSignal Transduction

Stichwörter der Autor:innen

BiomarkerDrug resistanceEpigeneticsOvarian cancermiR

Substanzen

MicroRNAsBiomarkers, Tumor

Autor:innen und Institutionen

  • Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA; Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma…
  • Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104,…

Förderung

  • NCI NIH HHS
  • DOD
  • NCI
  • Oklahoma Tobacco Settlement Endowment Trust
  • Public Health Foundation
  • Tobacco Settlement Endowment Trust
  • Ovarian Cancer Academy
  • Oklahoma Center for the Advancement of Science and Technology

Zitieren

APA

Dey Bhowmik, A., Shaw, P., Gopinatha Pillai, M. S., Rao, G., & Dwivedi, S. K. D. (2025). Evolving landscape of detection and targeting miRNA/epigenetics for therapeutic strategies in ovarian cancer. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217357

Vancouver

Dey Bhowmik A, Shaw P, Gopinatha Pillai MS, Rao G, Dwivedi SKD. Evolving landscape of detection and targeting miRNA/epigenetics for therapeutic strategies in ovarian cancer. Cancer Letters. 2025. doi:10.1016/j.canlet.2024.217357

BibTeX
@article{DeyBhowmik2025,
  author = {Dey Bhowmik, Arpan and Shaw, Pallab and Gopinatha Pillai, Mohan Shankar and Rao, Geeta and Dwivedi, Shailendra Kumar Dhar},
  title = {Evolving landscape of detection and targeting miRNA/epigenetics for therapeutic strategies in ovarian cancer},
  journal = {Cancer Letters},
  year = {2025},
  doi = {10.1016/j.canlet.2024.217357}
}
Kostenlos starten →